Press Releases

All Releases
AngioDynamics to Present at the UBS Global Healthcare Conference
May 11, 2015
ALBANY, N.Y. , May 11, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics to Present at the Bank of America Merrill Lynch Health Care Conference
May 05, 2015
ALBANY, N.Y. , May 5, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics Re-Entering Embolization Market
Apr 09, 2015

Company Announces Worldwide Licensing Agreement With EmboMedics Inc.

AngioDynamics Reports 2015 Third Quarter Financial Results
Apr 09, 2015
Third quarter fiscal 2015 net sales of $86.6 million ; flat vs. prior year, excluding the wind down of supply agreement and $1 million on a constant currency basis GAAP loss of $0.12 per share primarily due to one-time non-cash charges Non-GAAP adjusted net income of $0.12 per share, negatively
AngioDynamics to Present at the Needham & Company 14th Annual Healthcare Conference
Apr 07, 2015
ALBANY, N.Y. , April 7, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics to Report Fiscal 2015 Third Quarter Financial Results
Mar 26, 2015
ALBANY, N.Y. , March 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 third
AngioDynamics to Present at the Barclays Global Healthcare Conference
Feb 25, 2015
ALBANY, N.Y. , Feb. 25, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Receives Expanded "No Chest X-Ray" FDA Clearance for Celerity Tip Location System
Jan 29, 2015
ALBANY, N.Y. , Jan. 29, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) cleared an expanded
AngioDynamics Reports 2015 Second Quarter Financial Results
Jan 08, 2015
Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million ; 5% sales growth excluding supply agreement GAAP EPS of $0.04 ; Non-GAAP adjusted net income of $0.17 per share, a 21% YOY increase EBITDA of $11.9 million ; Adjusted EBITDA of $15.9 million , a 18% YOY increase Company raises
AngioDynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference
Jan 06, 2015
ALBANY, N.Y. , Jan. 6, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
Dec 17, 2014
ALBANY, N.Y. , Dec. 17, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second
AngioDynamics Awarded HealthTrust PICC Contract
Dec 09, 2014
ALBANY, N.Y. , Dec. 9, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC
AngioDynamics to Present at 26th Annual Piper Jaffray Healthcare Conference
Nov 25, 2014
ALBANY, N.Y. , Nov. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics to Present at Upcoming Investor Conferences
Nov 11, 2014
ALBANY, N.Y. , Nov. 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences
NanoKnife System Receives OPS Procedure Classification Codes in Germany
Oct 28, 2014
ALBANY, N.Y. , Oct. 28, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Germany Ministry of Health has issued an OPS (a procedure
AngioDynamics to be Added to the S&P SmallCap 600 Index
Oct 13, 2014
ALBANY, N.Y. , Oct. 13, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it will be added to the S&P SmallCap 600 Index and the GICS Life
AngioDynamics Reports 2015 First Quarter Financial Results
Oct 09, 2014
First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million ; Sales grew 5%, excluding supply agreement Q1 FY15 GAAP $0.02 ; Non-GAAP adjusted net income of $0.16 per share Q1 FY15 EBITDA of $10.8 million , Adjusted EBITDA of $15.3 million Company provides second quarter guidance and
AngioDynamics to Report Fiscal 2015 First Quarter Financial Results
Sep 25, 2014
ALBANY, N.Y. , Sept. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 first
AngioDynamics Sponsors Second Annual St. Jude Gala
Aug 21, 2014

Event to Benefit St. Jude Children's Research Hospital
Honors WGNA; Features Performance by Big Sky Country

AngioDynamics to Present at Canaccord Genuity 34th Annual Growth Conference
Aug 07, 2014
ALBANY, N.Y. , Aug. 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today Joseph M. DeVivo , President and Chief Executive Officer, is
Displaying 81 - 100 of 623

Copyright West LLC. Minimum 15 minutes delayed.